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reproduction in any medium, provided the original author and source are credited.SUMMARYHuman mesenchymal stem cells (hMSCs), which conventionally are isolated based on their adherence to plastic, are heterogeneous
and have poor growth and differentiation, limiting our ability to investigate their intrinsic characteristics. We report an improved pro-
spective clonal isolation technique and reveal that the combination of three cell-surface markers (LNGFR, THY-1, and VCAM-1) allows
for the selection of highly enriched clonogenic cells (one out of three isolated cells). Clonal characterization of LNGFR+THY-1+ cells
demonstrated cellular heterogeneity among the clones. Rapidly expanding clones (RECs) exhibited robust multilineage differentiation
and self-renewal potency, whereas the other clones tended to acquire cellular senescence via P16INK4a and exhibited frequent
genomic errors. Furthermore, RECs exhibited unique expression of VCAM-1 and higher cellular motility compared with the other
clones. The combination marker LNGFR+THY-1+VCAM-1hi+ (LTV) can be used selectively to isolate the most potent and genetically
stable MSCs.INTRODUCTION
Mesenchymal stem/stromal cells (MSCs) are defined as
nonhematopoietic, plastic-adherent, self-renewing cells
that are capable of in vitro trilineage differentiation into
fat, bone, and cartilage (Pittenger et al., 1999). Additional
plasticity of MSCs has been suggested by experiments
demonstrating their in vitro differentiation into myo-
cytes, neuron-like cells, and hepatocytes (Drost et al.,
2009; Galvin and Jones, 2002; Tao et al., 2009). Despite
these data, the term ‘‘MSCs’’ has been controversial, as a
definitive demonstration of their ‘‘stemness’’ by single-
cell isolation and in vivo serial transplantation experi-
ments has been lacking (Bianco et al., 2013). These
multipotent cells are found in various fetal and adult
human tissues, including bone marrow (BM), umbilical
cord blood (UCB), liver, and term placenta (Battula
et al., 2007; Erices et al., 2000; Yen et al., 2005; Zvaifler
et al., 2000). MSCs are multipotent and have low immu-
nogenicity, and therefore are considered as potential
candidates for a variety of clinical applications (Jung
et al., 2012; Stappenbeck and Miyoshi, 2009), including
cartilage reconstitution and the treatment of rheumatoid
arthritis, acute osteochondral fractures, spinal disk
injuries, and inherited diseases such as osteogenesis152 Stem Cell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authimperfecta (Guillot et al., 2008). However, to date, these
cells have been poorly characterized, which raises
significant concerns because human trials using MSCs
are currently under way.
MSCs can be retrospectively identified based on their
ability to form colony-forming unit fibroblasts (CFU-Fs)
in vitro (Friedenstein et al., 1974). Traditionally, the isola-
tion of MSCs from unfractionated whole BM (WBM) has
relied on their adherence to plastic dishes. This technique
gives rise to heterogeneous cell populations that frequently
are contaminated with osteoblasts and/or osteoprogenitor
cells, fat cells, reticular cells, macrophages, endothelial
cells, and hematopoietic cells (Pittenger et al., 1999).
Prolonged culture is often required to remove these
contaminants and obtain a reasonably pure population of
MSCs. However, during this process, the differentiation,
proliferation, andmigration potency of theMSCs gradually
diminishes as the cells acquire a more mature phenotype
(Kim et al., 2009; Rombouts and Ploemacher, 2003). In
an effort to overcome these problems, investigators have
made an intense effort to identify reliable MSC surface
markers that could facilitate the prospective isolation of
colony-initiating cells.
Various surface markers, including CD49a, CD73,
CD105, CD106 (VCAM-1), CD140b, CD146, CD271ors
Figure 1. Screening of Putative Surface Markers for Prospective Identification of hMSCs
(A) Human bone fragments were washed with PBS (BM cells) or treated with collagenase (CR cells).
(B) Expression ratio of the indicated surface markers in the CD45 and GPA cell populations. The data are shown as the ratio of the
expression of a given marker on CR cells versus BM cells (mean ± SEM, n = 5; *p < 0.1).
(C) Colony-forming assay of a single marker population (2,000 cells) in CR cells at 14 days (mean ± SEM, n = 6 per group; *p < 0.05).
(D) Assay measuring the negative linear relationship between the numbers of seeded cells (BM, CR, and CD45GPA CR cells) and sorted
cells, using a surface marker in CR cells.
(E) Clonogenic assay of single cells seeded into 96-well plates and cultured for 14 days (BM-MNC POIETICS were used in this assay;
mean ± SEM, n = 3; *p < 0.05).
See also Figure S1.
Stem Cell Reports
Direct Isolation Method for Functional Human MSCs(LNGFR), MSCA-1, and STRO-1, have been used alone or in
combination to isolate humanMSCs (hMSCs) (Aslan et al.,
2006; Battula et al., 2009; Boiret et al., 2005; Bu¨hring et al.,
2007; Gronthos et al., 2003; Quirici et al., 2002; Sacchetti
et al., 2007). CD49a, CD73, CD140b, and CD146 are
widely expressed in stromal cells (e.g., pericytes and retic-
ular cells) and thus are not unique to MSCs. STRO-1 is a
popular MSC marker and is often used in combination
with VCAM-1 for MSC isolation. However, these markers
are also found on some hematopoietic cells, and additional
markers, including CD45 and Glycophorin A (GPA), are
required to exclude contaminating cells (Gronthos et al.,
2003; Simmons and Torok-Storb, 1991). Therefore, the
identification of a combination of cell surface markers spe-
cific to hMSCs has remained an important prerequisite for
the repeated isolation of purified multipotent MSC
fractions.Stem CIn the present study, we performed a comprehensive
screening of putative surface markers to select the most
useful ones for prospectively identifying a pure MSC popu-
lation in human BM. We describe a significantly improved
method that enables the simple and reliable prospective
isolation of MSCs based on their expression of LNGFR,
THY-1, and VCAM-1.RESULTS
Identification of MSC Markers
We isolated fresh human BM cells using either the tradi-
tional method of flushing the BM or collagenase digestion
of crushed bone (collagenase-released [CR] cells), as previ-
ously described for a murine MSC isolation procedure
(Houlihan et al., 2012; Morikawa et al., 2009; Figure 1A).ell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authors 153
Figure 2. The LNGFR+THY-1+ Population Is Significantly Enriched for CFU-Fs with Potent Differentiation Potential
(A) Representative flow-cytometric profiles of human BM stained for LNGFR and THY-1.
(B) Numbers of CFU-Fs detected 14 days after plating 5,000 cells from each of the following groups: LNGFR+THY-1+, +/, /+, and /
cells (mean ± SEM, n = 12 per group; **p < 0.01).
(C) Assay of the negative linear relationship between the numbers of seeded LNGFR+THY-1+ and LNGFR+THY-1 cells.
(D) Phase-contrast micrographs of a colony of LNGFR+THY-1+ cells (phase), showing the potential of a LNGFR+THY-1+ colony to differ-
entiate into osteoblasts, chondrocytes, and adipocytes. Scale bar = 100 mm.
(E) Phase-contrast micrographs of LNGFR+THY-1+ and LNGFR+THY-1 colonies (passage 1). Arrows point to cells with larger amounts of
cytoplasm. Scale bar = 100 mm.
(F) Secondary CFU-Fs assays were performed with single cells sorted from LNGFR+THY-1+ and LNGFR+THY-1 colonies after one passage
(mean ± SEM, n = 3; **p < 0.01).
(legend continued on next page)
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cell types by plating 103, 104, or 105 cells, and counting
the wells with formed colonies. After a 2-week culture
period, we found that the CFU-F frequency was far greater
with CR cells than with BM cells using the standard isola-
tion method (BM: 3.3% ± 3.3%, 7.4% ± 7.4%, 0% ± 0%;
CR: 24.8% ± 5.2%, 35.6% ± 15.6%, 77.8% ± 22.2%; Fig-
ure S1A available online). Based on these findings, we
concluded that collagenase treatment and depletion of
hematopoietic cells increases the frequency of CFU-F
formation. This prompted us to search for putative cell-
surface markers specific to this potent subpopulation. To
that end, we used flow cytometry to screen >100 potential
markers on both BM and CR cells. We specifically looked
for ‘‘rare’’ (<0.1%) surface markers whose frequency in
the nonhematopoietic fraction increased following colla-
genase treatment. The frequencies of cells expressing
some known MSC markers increased among CR cells,
and in particular, cells expressing LNGFR and THY-1
increased significantly in the CR fraction compared with
flushed BM (CR/BM ratio: LNGFR: 8.75 ± 2.3; THY-1:
6.70 ± 1.3; Figure 1B).
To assess the purification efficiency of these potential
markers (THY-1 and LNGFR) and compare themwith previ-
ously validated MSC markers (MSCA-1, STRO-1, VCAM-1,
CD73, CD105, and CD146), we performedCFU-F assays us-
ing CR cells based on their expression of each marker. The
THY-1+ cells showed the greatest CFU-F frequency among
the fractions tested (Figure 1C). A limiting dilution assay
measuring the relationship between seeding density and
colony-forming efficiency also indicated that THY-1+ cells
had the highest clonogenic potential (1 CFU-F per 150 cells
seeded; Figure 1D). To determine whether a particular com-
bination of surface markers could select for a more potent
population of hMSCs, we examined cells that were positive
for each selected marker (LNGFR, MSCA-1, STRO-1,
VCAM-1, CD73, or CD105), combined with THY-1 expres-
sion (Figure 1E). Additionally, previously reported MSC
marker combinations, including LNGFR+CD140a+ and
LNGFR+CD146+, were tested (Figure S1B). Single-cell
assays demonstrated that LNGFR+THY-1+ cells had the
highest CFU-F potential (Figures 1E and S1B). Collectively,
the LNGFR+THY-1+ cells demonstrated a CFU-F frequency
that was 200,000 times higher than observed for unfrac-
tionated BM cells (LNGFR+THY-1+ cells versus BM cells: 1
per 5–6 cells seeded versus 1 per 1.23 106 cells seeded; Fig-(G) Flow-cytometric analysis of surface markers on LNGFR+THY-1+ cells
versus a matched isotype control (gray). Lineage cocktail: CD3, CD14
(H) Phase-contrast image of cultures of LNGFR+THY-1+ and LNGFRTHY
Scale bar = 100 mm.
(I) Total numbers of CFU-Cs counted on day 14 (mean± SEM, n = 3; **p <
See also Figures S2 and S3.
Stem Cures 1D and 1E). In addition, flow-cytometric analysis
showed that the LNGFR+THY-1+ population contained the
smallest percentage of hematopoietic cells (CD45+:
1.01%) and red blood cells (GPA+: 0.85%) among the com-
binations tested (Figure S1C).We confirmed by immunocy-
tochemistry that the LNGFR+THY-1+ population was not
contaminated by endothelial cells (CD31-staining nega-
tive) or osteogenic cells (osteocalcin-staining negative;
Figure S1D). Therefore, two-color immunostaining with
THY-1 and LNGFR is a reliable method for isolating MSCs
fromBMwithminimal contamination fromhematopoietic
cells.
hMSCs Exist Only in the LNGFR+THY-1+ Population
Two-color staining for LNGFR and THY-1 of WBM
revealed the presence of four distinct subpopulations
(LNGFR+THY-1+, +/, /+, and /; Figure 2A). We iso-
lated cells from each subpopulation and performed several
in vitro assays to determine their characteristics. The tradi-
tional CFU-F and limiting dilution assays indicated that
the number of colony-forming cells arising from each
subpopulation was highest in the LNGFR+THY-1+ sub-
population, with a frequency of one in six (Figures 2B
and 2C). When the in vitro mesenchymal lineage differ-
entiation potential was investigated, CFU-Fs from
LNGFR+THY-1+ cells robustly differentiated into adipo-
cytes, chondrocytes, and osteoblasts (Figure 2D). In
contrast, cells in the other subpopulations had extremely
low CFU-Fs (1/6,300 in LNGFR+THY-1) or no CFU-Fs
(LNGFRTHY-1 and LNGFRTHY-1+; Figures 2B and
2C). The few colonies that formed from LNGFR+THY-1
cells appeared to have nonfibroblastic shapes (Figure 2E,
arrows) and rarely formed secondary CFU-Fs when
reseeded, although 60% of CFU-Fs from LNGFR+THY-1+
cells produced secondary colonies under the same condi-
tions (Figure 2F). These results suggested that CFU-Fs in
the LNGFR+THY-1 population were not hMSCs. Multipo-
tent and self-renewing MSCs were only present in the
LNGFR+THY-1+ fraction.
Multicolor flow-cytometric analysis indicated that naive
LNGFR+THY-1+ cells uniformly expressed CD49a, CD49d,
CD73, CD140b, CD146, STRO-1 VCAM-1, and MSCA-1
(Figure 2G). In contrast, almost all of the cells were negative
for hematopoietic lineage markers (CD3, CD14, CD16,
CD19, CD20, CD45, CD56, and GPA), an embryonic stem
cell marker (SSEA-1), and an endothelial/hematopoietic, showing the percentage of cells that express the antigen (red line)
, CD16, CD19, CD20, and CD56.
-1+ cells after 14 days of culture in MethoCult medium (CFU-C assay).
0.01). BM-MNC POIETICS were used for all experiments in this figure.
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Direct Isolation Method for Functional Human MSCsstem cell (HSC) marker (CD34; Figure 2G). To confirm
that the LNGFR+THY-1+ population was devoid of
hematopoietic progenitor cells, we performed a colony-
forming units in culture (CFU-C) assay to detect hema-
topoietic progenitor cells. The results showed that
LNGFR+THY-1+ cells produced no CFU-Cs (Figure 2H).
However, LNGFRTHY-1+ cells, which exhibited no
CFU-F potential, formed >40 CFU-Cs per 5,000 cells
seeded under the same culture conditions (Figure 2I).
These data strongly suggested that LNGFR and THY-1
could be used for the prospective identification of a
rare and potent population of hMSCs.
We looked for the presence of LNGFR+THY-1+ cells in a
variety of other human tissues that contain MSC-like cells,
including placenta (amnion, chorion, and decidua), fat,
peripheral blood (PB, with or without G-CSFmobilization),
and UCB (Lee et al., 2004; Nagase et al., 2009; Zimmerlin
et al., 2010; Zvaifler et al., 2000). LNGFR+THY-1+ cells
were detected in the decidua but not the amnion
or chorion of the placenta (Figure S2A). Decidual
LNGFR+THY-1+ cells exhibited a high CFU-F potential
equivalent to that of BM-derived LNGFR+THY-1+ cells
(Figure S2B). Interestingly, both the LNGFR+THY-1 and
LNGFRTHY-1 fractions, derived from adipose tissue,
generated CFU-Fs, albeit less frequently than LNGFR+
THY-1+ cells (Figures S2C and S2D). We were unable to
detect LNGFR+THY-1+ cells among 106 PB or UCB cells;
however, a small number of LNGFR+THY-1+ cells that had
clonogenic potential were present in G-CSF-mobilized PB
(G-CSF mPB; Figures S2E and S2F).
In a previous study (Morikawa et al., 2009), we reported
that, after undergoing ex vivo expansion, intravenously
injected MSCs were trapped largely in the lung and
did not migrate to the BM compartment. To evaluate
homing of cultured and naive LNGFR+THY-1+ cells to
bone in vivo, we transplanted the cells into immuno-
deficient mice (Figure S3A). Mice injected with 2 3 105 to
1 nbsp;3 106 LNGFR+THY-1+ cells expanded in culture,
died from pulmonary embolism within a week, and no
human cells could be identified in the recipients’ BM. In
contrast, 3 months after the transplantation of 1 3 104
freshly isolated LNGFR+THY-1+ cells, wewere able to collect
human-derived cells from the recipients’ BM using species-
specific antibodies. We performed immunohistochemistry
after LNGFR+THY-1+ cell transplantation and observed
the transplant human cells in mouse BM. Human THY-1-
positive cells were detected in lung, skin, and subcutaneous
tissue; however, expression of a-SMA and alkaline phos-
phatase (ALP) was not detected (Figure S3B). To test
whether these surviving human cells retained their stem
cell properties, we sorted human THY-1+ cells and per-
formed several in vitro assays (Figure S3C). Following
expansion in vitro, the sorted human THY-1+ cells were156 Stem Cell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authcapable of colony formation and multilineage differentia-
tion into bone, cartilage, and fat cells (Figure S3D). These
data demonstrated that freshly isolated human LNGFR+
THY-1+ cells could home to the BMand retain their prolifer-
ative and multilineage differentiation potential in murine
recipients, although the engraftment efficiency was low.
Defining Subpopulations of CFU-Fs Using Single-Cell
Assays
To further define the differentiation and proliferation
potential of LNGFR+THY-1+ cells, we monitored colony
formation after single-cell seeding into a 96-well culture
dish (Figure 3A). Interestingly, analysis of their growth
kinetics revealed that single LNGFR+THY-1+-derived CFU-
Fs could be divided into three distinct subgroups: rapidly
expanding MSC clones (RECs: 16.4% ± 2.0%) that yielded
>105 cells by day 14, moderately expanding MSC clones
(MECs: 47.2% ± 2.9%) that took up to 21 days to yield 105
cells, and slowly expanding MSC clones that failed to
generate 105 cells after 1 month of culture (SECs: 36.3% ±
2.9%; Figure 3B). The subgroups had different cellular mor-
phologies. RECs were uniformly small and spindle-shaped,
whereas MECs and SECs were polymorphic and contained
cells with larger nuclei and enlarged cytoplasm (Figure 3C,
arrows in phase images). The heterogeneity among these
groups is also reflected in the different cell size of RECs
compared with MECs and SECs (Figure 3C). When the adi-
pogenic and osteogenic differentiation efficiencies of each
subgroup were compared, there were clearly more adipo-
genic cells in RECs than in MECs or SECs (REC: 99.3% ±
0.33%; MEC: 58.1% ± 6.26%; SEC: 22.2% ± 1.87%; Figures
3Dand3E). In addition, RECsexhibited thegreatest second-
ary colony-forming efficiency (RECs: 33.3% ± 9.6%; MECs:
8.9% ± 3.5%; SECs: 1.0% ± 0.58%) after the single-cell sort-
ing of each subgroup (Figure 3F). We established individual
MSC clones derived from single LNGFR+THY-1+ cells (n =
145; Table S1). All RECs were multipotent and capable of
differentiating into either all three lineages (adipogenic,
chondrogenic, and osteogenic [37/46: 80%]) or bilineage
cells (9/46: 20%). Although some MECs/SECs were unable
to differentiate (6/48: 13% and 7/51: 14%, respectively),
>60%ofMECs/SECs showed either tri- or bilineagedifferen-
tiation potential (38/48: 79% of MECs and 32/51: 62% of
SECs), indicating that most of the CFU-Fs derived from
LNGFR+THY-1+ cells were multipotent. These data sug-
gested that there is a functional hierarchy among CFU-Fs
derived from clonal LNGFR+THY-1+ cells, with RECs
exhibiting the most potent stem-like characteristics.
Cultured MSCs Undergo Cellular Senescence via
P16INK4a
We observed a greater increase in senescence-associated
beta-galactosidase (SA-b-gal)-positive cells in MECs andors
Figure 3. Clonal Assay of LNGFR+THY-1+
Cells
(A) Single-cell assay in a LNGFR+THY-1+
population. Representative image of a
typical 96-well culture plate (day 21 after
initial seeding) shows colony-forming wells.
(B) Single-cell sorting and in vitro expan-
sion reveals three distinct MSC sub-
populations of rapidly, moderately, or slowly
expanding MSC clones (RECs, MECs, and
SECs, respectively). Growth curves of repre-
sentative RECs, MECs, and SECs, and the
percentage of each colony type present are
shown.
(C) Phase-contrast micrograph showing the
cellular morphologies of RECs, MECs, and
SECs. The arrows point to larger MECs and
SECs with larger nuclei. Scale bar = 100 mm.
(D) Differentiation of each colony type into
adipocytes and osteoblasts. Scale bar =
100 mm.
(E) Quantitative analysis of the differentia-
tion capacity of each colony type (differ-
entiation cells / nuclei; mean ± SEM, n = 6;
*p < 0.05).
(F) Average number of secondary CFU-Fs in
wells for each cell type at 6 weeks (mean ±
SEM, n = 3; *p < 0.05). BM-MNC POIETICS
were used for all experiments in this figure.
See also Table S1.
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cells undergo cellular senescence (Figures 4A and 4B). To
assess the genomic stability of RECs, MECs, and SECs, we
performed array-based comparative genomic hybridization
(aCGH) to investigate aneuploidy and genomic abnormal-
ities (Ben-David et al., 2011; Spits et al., 2008). We found
that MECs and SECs accumulated nonoverlapping copy-
number variations (CNVs), indicating de novo genomic
DNA abnormalities, although no errors were identified in
any of the RECs studied (Table S2). Since DNA damage
induces premature senescence via cell-cycle regulatory
proteins in many cell types (Galderisi et al., 2009), weStem Cmeasured the gene expression of the tumor suppressor
P14ARF and the cdk inhibitors P16INK4a and P21 in each
group. A significant increase in P16INK4a expression was
observed in MECs and SECs compared with RECs, in
contrast to P21 and P14ARF expression (Figure 4C).
Therefore, cellular senescence in MECs and SECs might
be triggered by de novo genomic DNA abnormalities and
increased P16INK4a expression.
Notably, a dose-response curve plotting the CFU-F
number against the number of LNGFR+THY-1+ cells plated
per well did not show a linear relationship. Instead, we
obtained fewer than expected CFU-Fs from the higher cellell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authors 157
Figure 4. Heterogeneity in the MSC Compartment
(A) SA-b-gal assay of RECs, MECs, and SECs cultured in a glass chamber (at 6 weeks). Scale bar = 50 mm.
(B) Quantitative analysis of SA-b-gal+ cells in RECs, MECs, and SECs (mean ± SEM, n = 3 per group; **p < 0.01).
(C) Relative expression of P14ARF, P16INK4a, and P21 in 6-week cultured cells by real-time RT-PCR (mean ± SEM, n = 3; *p < 0.1,
**p < 0.01; n.s., not significant).
See also Figure S4 and Table S2.
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Direct Isolation Method for Functional Human MSCsconcentrations (Figure S4A). In addition, we observed
different growth kinetics with single REC, LNGFR+THY-1+
cells (1,000 cells), and WBM cells (1 3 106). Specifically,
single RECs continued to grow without senescence, gener-
ating >1012 cells after 10 weeks, whereas LNGFR+THY-1+
cells stopped proliferating after 6 weeks and yielded signif-
icantly fewer cells (1010 cells; Figure S4B). Logically, 1,000
LNGFR+THY-1+ cells should contain 170 CFU-Fs, with
30 comprised of RECs, 90 comprised of MECs, and
50 comprised of SECs. However, the total number of
LNGFR+THY-1+ growth cells was much smaller than we
anticipated. To analyze this phenomenon in detail and
exclude the possibility of cellular overcrowding, we per-
formed a coculture assay using RECs and SECs at low cell
numbers (Figure S4C). Following 4 weeks in coculture,
REC proliferation was markedly reduced in the presence
of SECs (Figures S4D and S4E). These results suggest that
the SEC-mediated inhibition of REC proliferation is inde-
pendent of cell density. Therefore, the direct isolation of
RECs should be the most effective way to obtain highly
pure MSCs from mixed CFU-Fs.
VCAM-1 and CD49d Are Specifically Expressed
in RECs
Isolation of RECs is difficult because it requires single-cell
sorting of LNGFR+THY-1+ cells followed by a minimum of
2weeks in culture. Given the characteristics of RECs, which158 Stem Cell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authmake them attractive for therapeutic applications, we
attempted to identify REC-specific markers. ‘‘Index sort-
ing’’ enabled us to identify cells in the LNGFR+THY-1+
fraction that gave rise to RECs. There was a higher concen-
tration of RECs in the LNGFR and THY-1 bright fraction
(66.6% in RECs); however, MECs and SECs were also pre-
sent in the same region (51.4% in MECs, 45.0% in SECs;
Figures S5A–S5C). Similarly, measurements of cell size
(forward scatter) and complexity (side scatter) failed to
distinguish among the groups (Figure S5D).
The differential expression of various cell-surface mole-
cules was explored further in each of the three cell types
(Figures 5A and S5E). The observation of moderate
VCAM-1 and CD49d (Integrin a4) expression on RECs, in
contrast to their absence on MECs and SECs, was particu-
larly noteworthy (Figure 5A). VCAM-1 and Ki67 immuno-
histological staining indicated a higher proliferation in
RECs (19%) compared with MECs or SECs (<5%; Figures
5B and 5C). Quantitative PCR analysis confirmed a signifi-
cantly higher expression of VCAM-1 in RECs compared
with MECs and SECs (Figure 5D).
Cell Motility Is Mediated via VCAM-1 in RECs
VCAM-1 is known to bind to integrin a4b1 (VLA-4:
CD49d/CD29), and this interaction is crucial for both
rolling and adhesion of several cell types on the
vascular endothelium prior to transendothelial traffickingors
Figure 5. VCAM-1 Identifies Rapidly Dividing MSCs
(A) Expression of the indicated surface markers in RECs, MECs, and SECs (6 weeks in culture). Shown is the percentage of cells that express
the antigen (line) versus a matched isotype control (gray).
(B) Immunocytochemistry of MSC subpopulation with VCAM-1 (green), Ki67 (red), and nuclei (blue). Scale bar = 100 mm.
(C) Quantitative analysis of Ki67+ cells in RECs, MECs, and SECs (mean ± SEM, n = 3 per group; **p < 0.01).
(D) Relative expression of VCAM-1 marker in cultured cells (6 weeks) by real-time RT-PCR (mean ± SEM, n = 3; *p < 0.05, **p < 0.01).
See also Figure S5.
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Direct Isolation Method for Functional Human MSCs(Papayannopoulou et al., 1998). A transwell migration
assay revealed that RECs exhibited significantly greater
migration ability than MECs or SECs; however, the
motility of the RECs was abrogated in the presence of
function-blocking antibodies directed against VCAM-1 or
CD49d (Figures 6A and 6B). Microfilaments anchor to
the cell membrane and are involved in cytoskeleton
organization to produce effective cell motility (Gumbiner,
1996). F-actin is a major component of the micro-
filaments that are formed by polymerization ofmonomeric
actin (G-actin). The formation of F-actin is balanced by
an equilibrium reaction of G-actin incorporation and
dissociation; typically, however, nonmotile cells accumu-
late large bundles of microfilaments known as stress fibers
(Schratt et al., 2002). We therefore analyzed stress-fiber
formation among the hMSC subgroups. Large tubular
components (F-actin+) were detected in MECs and SECs,
but not in RECs (Figure 6C). After cell culture withStem Cblocking antibody (anti-VCAM-1 or anti-CD49d), REC
morphology was changed and stress-fiber components
were increased (Figures 6C and 6D). Therefore, the
enhancedmigration capabilities of RECsmay be associated
with expression of VCAM-1 and CD49d. The formation of
stress fibers is often accompanied by morphological
changes of cells, typically characterized by enlargement
of the cytoplasm (Wada et al., 2011). A comparison of
cell widths (minor axis) clearly revealed that one REC cell
was smaller than the others (Figure 6E). Notably, the cell
width of RECs increased in response to VCAM-1 or CD49
blockade (Figure 6E).
A recent report suggested that artificial overexpression of
LLP2A (ligand of CD49d) on hMSCs increases their migra-
tion to murine BM (Guan et al., 2012). Interestingly,
VCAM-1 is also an equally effective ligand for CD49d.
Following systemic infusion of RECs into murine recipi-
ents, there was no evidence of focal lung trapping,ell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authors 159
Figure 6. Expression of VCAM-1 and
CD49d Correlated with the Migration
Ability of MSCs
(A) Migration assay in vitro. A total of 1.53
104 cells (RECs, MECs, and SECs) were re-
suspended in DMEM containing 1% FBS and
10 mg/ml aphidicolin, and allowed to
migrate toward the culture medium sup-
plemented with 20% FBS in the lower
chamber.
(B) Migration assay of RECs, MECs, and SECs
with or without blocking antibody
(‘‘Normal’’ indicates no antibody treat-
ment). The cells were incubated with each
antibody (isotype control [mouse IgG1],
anti-VCAM-1 [51-10C9], anti-CD49d [9F10],
each at 10 mg/ml) for 30 min prior to assay
(mean ± SEM, n = 3 per group; *p < 0.05,
**p < 0.01).
(C) The distribution of the indicated F-actin
(green) and a-tubulin (red) was monitored
by immunofluorescence and microscopy
(after 4 days). The small box represents a
high-resolution image. Scale bar = 100 mm.
(D) Quantitative analysis of F-actin+ cells
(mean ± SEM, n = 3 per group; **p < 0.01).
(E) Quantitative analysis of cell width (n =
30) in RECs, MECs, and SECs (**p < 0.01).
(F) Imaging of transplanted cultured MSCs
in vivo. A Luciferase image of cell migration
in the recipient animals at 1 day post-
injection of 13 105 cultured cells (infected
with Venus-ffLuc lentivirus) is shown.
(G) Quantitation of luciferase activity in
recipient animals. Luminescent intensity
was significantly increased after injection
of the cultured MSCs and MECs/SECs in lung
regions (mean ± SEM, n = 3 per group;
**p < 0.01).
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were largely sequestered in the pulmonary vasculature
(Figures 6F and 6G). These observations led us to speculate
that VCAM-1 expression may be essential to maintain the
RECs’ morphology and thus their in vitro and in vivo
motility.160 Stem Cell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The AuthFurther Purification of Functional MSCs
Using VCAM-1 as a specificmarker, we attempted to isolate
RECs from cultured MSCs or directly from fresh BM cells.
Based on flow cytometry, freshly isolated LNGFR+THY-1+
cells uniformly expressed VCAM-1 (Figure 2G), but this
gradually decreased with time during ex vivo expansionors
Figure 7. Isolation of Functional MSCs in
Culture and Fresh BM Cells
(A) Culture-dependent reduction in the
frequency of VCAM-1+ cells in the
LNGFR+THY-1+ cell population.
(B) Colony-forming potential of cultured
VCAM-1+ or VCAM-1 cells derived from the
LNGFR+THY-1+ cell population after 4 weeks
and 8 weeks (mean ± SEM, n = 5;
**p < 0.01).
(C) Direct isolation of RECs from fresh BM
cells.
(D) Colony-forming potential of low-
positive or high-positive VCAM-1 cells in
the LNGFR+THY-1+ cell population (mean ±
SEM, n = 3; *p < 0.05).
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and compared the CFU-Fs of each cultured fraction. We
found that VCAM-1+ cells had a far greater clonogenicity
compared with VCAM-1 cells (Figure 7B). We then exam-
ined the utility of VCAM-1 for isolating RECs directly from
fresh WBM (Figure 7C). After single-cell sorting into 96-
well plates, LNGFR+THY-1+VCAM-1hi+ (LTV) cells showed
2-fold higher CFU-Fs compared with LNGFR+THY-1+ (Fig-
ure 7D). Surprisingly, 87% of LTV CFU-Fs were RECs,
whereas LNGFR+THY-1+- and LNGFR+THY-1+VCAM-1lo+-
derived CFU-Fs contained far less RECs (16.4% and
10.2%, respectively; Figure 7D). Therefore, VCAM-1 can
be used as a marker for enriching multipotent/proliferative
cells (RECs) from both culture-expanded MSCs and fresh
BM cells.DISCUSSION
Despite the widespread clinical use of hMSCs, there are
fundamental gaps in our knowledge of basic MSC biology.
In contrast to HSCs, the molecular mechanisms that
maintain MSCs in their undifferentiated state or deter-
mine their differentiation pathways are still poorly under-
stood. Due to the limitations of the methods used to
isolate MSCs, it has not been possible to obtain a suffi-
ciently pure MSC population to address these questions.
In the current study, we have demonstrated that
LNGFR+THY-1+ cells in human BM constitute an
extremely pure MSC population. The clonogenic potential
of single-seeded LNGFR+THY-1+ MSCs, cultured in stan-
dard medium (Dulbecco’s modified Eagle’s mediumStem C[DMEM] + 20% fetal bovine serum [FBS]) exceeds that of
other reported isolation methods (STRO-1+VCAM-1+
[Gronthos et al., 2003], MSCA-1+CD56 [Battula et al.,
2009], LNGFR+CD140b+ [Bu¨hring et al., 2007], and
LNGFR+CD146+ [Tormin et al., 2011]). Murine HSCs can
be isolated based on CD34, c-Kit+, Sca-1+, and Lineage
expression, which yields one HSC per five cells
(Matsuzaki et al., 2004). Our isolation method for hMSCs
achieves a level of purity similar to that of mouse HSCs.
Moreover, because LNGFR+THY-1+ cells contain the least
number of hematopoietic cells, this combination enables
the convenient isolation of MSCs based on the surface
expression of only two antigens. This simple and easy
isolation method should facilitate further studies and
improve our basic understanding of the primary character-
istics of MSCs.
Using highly enriched primary MSCs, one can perform
clonal experiments easily and efficiently. Several groups
have reported that MSCs are heterogeneous with respect
to their morphological appearance (Kucia et al., 2007a,
2007b; Pittenger et al., 1999; Prockop et al., 2001). Our
findings confirm that CFU-Fs derived from a single
LNGFR+THY-1+ cell can be divided into three functionally
distinct subpopulations termed RECs, MECs, and SECs.
RECs exhibited robust multilineage differentiation and
self-renewal potency. We therefore consider RECs to be
the most primitive and undifferentiated population in
CFU-Fs. In a previous report, upregulation of p16Ink4a
and p19Arf by loss of the transcriptional repressor Bmi-1
led to defective self-renewal of adult HSCs and neural
stem cells, but was less critical for generating the differenti-
ated progeny of these cell types (Park et al., 2003; Molofskyell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The Authors 161
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expression of the two commonly known biomarkers for
cellular senescence, SA-b-gal and P16INK4a. In contrast,
P14ARF, which is generated by alternative splicing from
the INK4a locus and P21, was not affected. We therefore
speculate that the self-renewal capacity of cultured MSCs
is mediated by an unknown mechanism rather than by
BMI-1 regulation.
VCAM-1 encodes a leukocyte adhesion molecule whose
expression is restricted to endothelial cells and subpopula-
tions of BMcells (Osborn et al., 1989). VCAM-1 binds to the
integrin a4b1 and integrin a4b7 on circulating monocytes,
granulocytes, and lymphocytes (Elices et al., 1990; Osborn
et al., 1989). Increased expression of VCAM-1 has been
reported in various cancer cell types, including breast,
gastric, renal carcinoma, and melanomas (Ding et al.,
2003; Minn et al., 2005). It has been suggested that the
VCAM-1-CD49d interaction promotes cancer cell survival
and migration (Klemke et al., 2007). In this study, we
demonstrated that RECs have higher expression of
VCAM-1 compared with MECs or SECs, and blockade of
the VCAM-1-CD49d interaction significantly diminished
transwell migration and increased stress-fiber formation.
The functional difference between the groups relates to
the organization of the F-actin cytoskeleton, since the rigid
cytoskeletal structure inhibits their ability to transmigrate
across the vascular endothelium (Morales-Ruiz et al.,
2000). Therefore, we speculate that RECs interact with
each other through VCAM-1-CD49d, thereby maintaining
their primitive state, including self-renewal, multilineage
potential, and migratory capacity.
In this study we have described methods for the selec-
tive isolation of primitive hMSCs that may prove advan-
tageous both experimentally and therapeutically. The
identification of the combination marker LTV makes it
possible to prospectively isolate functional hMSCs
directly from BM. Using these cells, we may be able to
tease out the complex molecular mechanisms that
govern the undifferentiated state of hMSCs. Additionally,
these markers may allow visualization of hMSCs in vivo,
thereby helping to uncover their physiological and
pathophysiological roles. The use of VCAM-1 as an
REC-selective marker facilitates the isolation of enriched
MSCs from a heterogeneous population of cultured
MSCs that represents mixed CFU-Fs. Since we demon-
strated that the coexistence of SECs alters the self-
renewal and differentiation potency of RECs in culture,
the isolation of VCAM-1+ cells from cultured hMSCs
may prove useful therapeutically. In conclusion, our
data should help to unravel the fundamental cellular
and molecular biology of MSCs. This information is
critical if MSCs are to be used effectively and safely in
regenerative therapy.162 Stem Cell Reports j Vol. 1 j 152–165 j August 6, 2013 j ª2013 The AuthEXPERIMENTAL PROCEDURES
Tissue Collection
Heads of femurs were collected from patients (22–80 years old)
who had undergone hip replacement arthroplasty at Keio
University Hospital, Tokyo. In total, 23 biological samples were
obtained and used for the experiments described herein.
Placenta, fat, PB, and UCB samples were also collected and stored
in accordance with Keio University protocols and guidelines.
Approval for the study was obtained from the Research Ethics
Committee of the Keio University School of Medicine (No.
18-26), and patient recruitment was undertaken with written
informed consent.
Cell Preparation
The heads of femurs were dissected and crushed with a pestle, af-
ter which the crushed bones were washed gently once in PBS to
collect BM cells. The bone fragments were incubated for 2 hr at
37C in DMEM (Invitrogen) in the presence of 0.2% collagenase
(cell dissociation grade; Wako Chemicals) and 25 mg/ml deoxyri-
bonuclease I (Sigma-Aldrich) to yield a suspension of CR cells.
The CR and BM cells were then used in the initial experiments
to define prospective markers for the identification of MSCs.
Placenta and fat-tissue experiments were also used for BM isola-
tion protocols as described in the Supplemental Experimental
Procedures.
Antibody Staining and Flow Cytometry
Cells were suspended in ice-cold Hank’s balanced salt solution at
1–53 107 cells/ml and then stained for 30min on icewith amono-
clonal antibody as described in the Supplemental Experimental
Procedures. The antibodies used were LNGFR-PE (Miltenyi Biotec),
THY-1-FITC, and VCAM-1-APC (BD PharMingen, Biolegend).
Flow-cytometric analysis and sorting were performed on a triple-
laser MoFlo (Beckman Coulter), FACSVantage SE, or FACSCalibur
flow cytometer (Becton Dickinson), and the data were analyzed
using Flowjo software (Tree Star). Analysis of cell populations
expressing varying combinations of LNGFR and THY-1 on their
surface from the different tissues routinely demonstrated 99%
purity by flow cytometry.
Limiting Dilution Assays
The sorted cells were seeded at different concentrations into 96-
well plates. After 14 days, wells with no colonies were included
in the count for each population. The concentration of plated cells
that resulted in 37% of the wells being negative for colony growth
was taken as the cell concentration that yielded one CFU-F/well
(Bacon and Sytkowski, 1987). Populations of sorted cells that
were >99% pure were routinely prepared.
Single-Cell Sorting and Secondary CFU-F Assays
Flow-cytometric analyses and the collection of single cells for
CFU-F assays were carried out using a FACSVantage SE cytometer.
The cells were sorted directly into separate wells of a 96-
well plate containing 200 ml of medium using a CloneCyt auto-
mated cell deposition unit. Calibration of the clone sorting
using fluorescent beads showed that <1% of the wells receivedors
Stem Cell Reports
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performed by flow cytometry, seeding single propidium iodide
(PI)-negative cells (living cells) from a starting population of
cultured cells.DNA Preparation and Quality Assessments
Genomic DNA was isolated using a QIAGEN DNeasy Blood &
Tissue Kit and Agilent’s recommended procedure from 5 3 106
cells (RECs, MECs, and SECs at 6 weeks) as described in the
Supplemental Experimental Procedures.Oligonucleotide aCGH Analysis
aCGH experiments were performed according to the manufac-
turer’s protocol (Agilent oligonucleotide array-based CGH for
genomic DNA analysis, version 6.0, direct method) as described
in the Supplemental Experimental Procedures. All aCGH data are
available for viewing at the Gene Expression Omnibus (GEO)
under accession number GSE34484.Index Sorting Assay
Index sorting was carried out according to the instrument user’s
guide (FACSVantage SE option and assembly; Becton Dickinson
Biosciences). Index sorting facilitates the linkage of marker expres-
sion information from an individual cell with its flow-cytometric
profile.Migration Assays
Migration assayswere performed using polyethylene terephthalate
filters with 8 mm pores (BD Biocoat) separating the upper and
lower chambers as described in the Supplemental Experimental
Procedures.Imaging of Transplanted Cultured MSCs In Vivo
RECs, MECs/SECs, and cultured MSCs were expanded and then
infected with Venus-ffLuc lentivirus (the Venus fluorescent and
luminescent fusion protein; Hara-Miyauchi et al., 2012). Venus+-
infected cells (1 3 105 cells) were then sorted and transplanted
intravenously. One day postinjection, the treated mice were anes-
thetized and given D-luciferin (150 mg/kg body weight) i.p. To
quantify themeasured light, regions of interest (ROIs) were defined
as lungs, and all values were examined from an equal ROI by
Xenogen-IVIS 100-cooled CCD optical macroscopic imaging
system (SC BioScience) as described in the Supplemental Experi-
mental Procedures.Statistical Analysis
Quantitative data are presented as the mean ± SEM from represen-
tative experiments (n R 3). For the statistical analysis, the data
were evaluated with a Student’s t test; p values < 0.05 were consid-
ered significant.ACCESSION NUMBERS
The Gene Expression Omnibus accession number for CGH array
reported in this paper is GSE34484.Stem CSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, five figures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2013.06.001.
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